期刊文献+

血清降钙素原和感染可能性评分对危重症患者感染预测的比较研究 被引量:18

Comparative study of procalcitonin serum level and infection probability score for the diagnosis of severe infection in ICU patients
下载PDF
导出
摘要 目的比较血清降钙素原(PCT)和感染可能性评分(IPS)在评估危重症患者感染中的价值。方法对不明原因全身炎症反应综合征(SIRS)和(或)伴有休克的患者,观察其出现SIRS首个24h的临床相关感染指标和PCT值。以血清PCT≥0.5ng/mL和IPS>14分别为评估感染的阈值,根据最终临床感染诊断比较IPS和PCT值在预测感染中的价值。结果47例患者入选,血清PCT检测感染的敏感性70.7%,特异性83.3%,其阳性预测值96.7%,阴性预测值29.4%,阳性似然比4.24。IPS检测感染的敏感性75.6%,特异性66.7%,阳性预测值93.9%,阴性预测值28.6%,阳性似然比2.27。结论血清PCT是评价感染较好的生化指标,其预测感染价值特别是特异性优于IPS。 Objective To evaluate the performance of procalcitonin (PCT) and infection probability score (IPS) as the marker of infection in critically ill patients.Methods Patients: Critically ill patients with SIRS and/or uncertain shock. Measurements: The serum PCT and IPS were determined within 24 hours after clinical onset of SIRS , the clinical status and biomarkers were also recorded. At cut-off values of PCT≥0.5 ng/mL and IPS>14, we compared the value of PCT and IPS in diagnosing the infection.Results 47 patients were enrolled. Compared with IPS, the serum PCT level had lower sensitivity (70.7% versus 75.6%), an ideal specificity (83.3% versus 66.7%), similar positive predictive value(96.7% versus 93.9 %) and negative predictive value (29.4% versus 28.6%). The positive likelihood ratio of PCT was better than IPS(4.24 versus 2.27). Conclusions In the present study PCT was found to be a more accurate diagnostic parameter for differentiating infectious SIRS and non-infectious SIRS better than IPS.
出处 《中国急救医学》 CAS CSCD 北大核心 2005年第6期391-394,共4页 Chinese Journal of Critical Care Medicine
关键词 血清降钙素原 感染可能性评分 感染 危重症 Procalcitonin(PCT) Infection probability score(IPS) Infection Critically ill patients
  • 相关文献

参考文献16

  • 1Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[ J ]. Crit Care Med, 2004, 32(3) :858 - 873.
  • 2Daliana PB, Christian M, Lopes Ferreira F, et al. Infection Probability Score (IPS) : A method to help assess the probability of infection in critically ill patients [ J ]. Cfit Care Med, 2003 ,31( 11 ): 2579 - 2583.
  • 3Bone RC, Balk RA, Cohen IL, et al. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference.Definitions for sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis[ J ]. Crit Care Med , 1992 , 20 : 864 - 874.
  • 4Wanner GA, Keel M, Steckholzer U, et al. Relationship between pro-calcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients[ J ]. Crit Care Med, 2000 , 28(4), 950 - 957.
  • 5Riche FC, Cholley BP, kaisne MJ, et al. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis [ J ]. Surgery,2003, 133(3) :257 - 262.
  • 6Brunkhorst FM, Wegscheider K, Forycki ZF, et al. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis severe, sepsis and septic shock [ J ]. Intensive Care Med, 2000,26(suppl) : S48 - S52.
  • 7Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin - 6, and interleukin - 8 in critically ill patients admitted with suspected sepsis [ J ]. Am J Respir Crit Care Med, 2001,164:396 - 402.
  • 8Muller B, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit [ J ]. Crit Care Med , 2000,28:977 - 983.
  • 9汪明明,崔速南,张景遥,孙玉秋,史兆章,张娟.血清降钙素原测定在感染性疾病中的诊断意义[J].中国抗感染化疗杂志,2002,2(4):215-217. 被引量:41
  • 10Yi - Ling Chart, Ching - Ping Tseng, Pei - tuei Tsay, et al.Procalcitonin as a marker of bacterial infection in the emergency department : an observational study[ J ] . Crit Care Med, 2004 , 8 ( 1 ) : R12 - R20.

二级参考文献13

  • 1Shimetani N, Shimetani K, Mori M. Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitis. Scand J Clin Lab Invest,2001,61:567.
  • 2Brandt ME, Warnock DW. Epidemiology, clinical manifestations,and therapy of infections caused by dematiaceous fungi . J Chemother, 2003, 15(Suppl 2): 36.
  • 3Micharl M Procalcitonin (PCT): A new , innovative infection parameter. New york :Ge org thieme verlag stuttgart , 2000,7-8;15-26.
  • 4Nosari A, Oreste P, Cairoli R, et al. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion Am J Hematol, 2001, 68: 231.
  • 5Bayer L, Schontube M, Dorffel W. C-reactive protein, Il-6 and procalcitonin as infection parameters in children with oncologic diseases. Klin Padiatr, 2000, 212: 326.
  • 6彭道泉.诊断性试验研究及评价[A].见:赵水平,彭道泉主编.现代临床科研方法学 第1版[C].长沙:中南大学出版社,2001.35.
  • 7Guerin S. Evaluation of the detection of procalcitonin by an immno-chromatography test: Brahms PCT-Q[J]. Ann Biol Clin (Paris),2000,58:613-614
  • 8Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of Procalcitonin [J]. Physiol Res,2000,49:S57-S61
  • 9Casado Flores J,Blanco Quiros A. Procalcitonin,A new marker for bacterial infecton[J]. An Esp Pediatr,2001,54:69-73
  • 10Korppi M, Remes S. Serum procalcitonin in pneumococcal pneumonia in children [J]. Eur Respir J, 2001,17:623-627

共引文献60

同被引文献135

引证文献18

二级引证文献240

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部